[1]
JAIKANTH CHANDRASEKARAN, INDHUMATHI THILLAI, PREMA GURUMURTHY, and KOTTURATHU MAMMEN CHERIAN, “ANTINEOPLASTIC AND PROTEOMIC SIGNATURE OF SIMVASTATIN TREATED CD44+/ CD24- TRIPLE NEGATIVE BREAST CANCER STEM -LIKE CELLS: Pharmaceutical Science-Pharmacology”, Int J Life Sci Pharm Res, vol. 7, no. 2, pp. 5–20, Jul. 2022.